Saturday 17 October 2026 Export KRYS’s income statement to Excel — free account

Krystal Biotech, Inc.

Krystal Biotech, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $389.1 million, up 33.9% from fiscal 2024. In the quarter to June 2026, revenue grew 24.1%, EPS grew 39.1% and free cash flow grew 40.1%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

316.58 13.42 −4.07%

Follow KRYS

Alert me

Market cap: $9.8B
P/E: 38.3×
Fwd P/E: 38.6×
Dividend yield: —
F-score: 7/9
Altman Z: 39.03
Beneish M: −2.27
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	25.62	34.82	33.33	44.94
P/S ratio Full definition →		13.70	18.34	18.13	24.92
P/FCF ratio Full definition →		30.79	37.69	31.87	42.57
P/Operating CF Full definition →		128.88	92.07	94.12	146.75
P/B ratio Full definition →		4.49	5.85	5.93	8.08
Price to Tangible BV Full definition →		4.49	5.85	5.93	8.08
EV/Sales Full definition →		11.74	16.21	16.16	23.00
EV/EBITDA Full definition →		26.58	37.58	36.37	49.55
EV/Operating CF Full definition →		24.86	31.40	26.94	37.19
EV/FCF Full definition →		26.38	33.31	28.40	39.29
Quick Ratio Full definition →		9.43	9.28	8.82	7.73
Current Ratio Full definition →		10.14	9.95	9.46	8.32
Net Debt/EBITDA Full definition →		(17.01)	(17.98)	(14.86)	(14.10)
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.34	0.33	0.34	0.33
Operating CF/Net income Full definition →		0.50	1.51	1.44	1.37
Capex/Depreciation Full definition →		(1.06)	(1.21)	(4.14)	(2.28)
Research and Development Expense of Revenue Full definition →		14.91%	13.81%	13.18%	12.18%
Selling, General and Administrative Expense of Revenue Full definition →		38.42%	38.70%	35.25%	33.43%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		13.45%	12.85%	11.70%	11.87%
Graham Net Nets Full definition →		0.16	0.13	0.12	0.08
Graham Number Full definition →		78.06	81.93	87.19	92.54
Earnings Yield Full definition →		3.90%	2.87%	3.00%	2.23%
Free Cash Flow Yield Full definition →		3.25%	2.65%	3.14%	2.35%
Revenue per Share Full definition →		3.38	3.70	3.97	4.04
Operating CF per Share Full definition →		1.37	2.68	2.74	2.53
Capex per Share Full definition →		(0.06)	(0.07)	(0.24)	(0.12)
Free Cash Flow per Share Full definition →		1.31	2.60	2.50	2.41
Cash per Share Full definition →		25.25	28.60	28.11	28.64
Shareholders Equity per Share Full definition →		39.30	42.14	43.59	46.03
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		39.30	42.14	43.59	46.03
Free Cash Flow Full definition →		37.96	75.37	73.23	71.22
Working Capital Full definition →		834.38	921.66	911.94	932.25
Capital Expenditures Full definition →		(1.70)	(2.14)	(7.15)	(3.56)
Net Current Asset Value Full definition →		823.43	910.37	899.50	918.13
EV/EBIT Full definition →		27.65	39.11	37.72	51.22
Capex to Sales Full definition →		0.02	0.02	0.06	0.03
Price to Operating Income Full definition →		32.26	44.24	42.33	55.50
Other line items
Average Receivables Full definition →		113.47	116.09	115.14	125.05
Average Payables Full definition →		3.84	4.11	3.38	6.83
Average Inventory Full definition →		28.11	33.49	36.29	38.30
Average Assets Full definition →		1,111.21	1,194.82	1,235.69	1,319.52
Average Common Equity Full definition →		1,011.86	1,082.97	1,130.70	1,199.89

Show all line items

Columns are period end dates

Stockrow Weekly